(99m)Tc-sestamibi SPECT/CT and (18)F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma

(18)F-fluorodeoxiglucose ((18)F-FDG)-PET/CT has been widely used to evaluate multiple myeloma. (99m)Tc-sestamibi (MIBI) scintigraphy has also been proposed for assessing multiple myeloma, but its use with state-of-the-art single-photon emission computed tomography/computed tomography (SPECT/CT) tech...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosci, Camila, Pericole, Fernando V., Oliveira, Gislaine B., Delamain, Marcia T., Takahashi, Maria E.S., Carvalheira, José Barreto C., Etchebehere, Elba C.S.C., Santos, Allan O., Miranda, Eliana C. M., Lima, Mariana C.L., Amorim, Barbara J., de Souza, Carmino A., Lorand-Metze, Irene, Ramos, Celso D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497601/
https://www.ncbi.nlm.nih.gov/pubmed/32732603
http://dx.doi.org/10.1097/MNM.0000000000001259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497601/
https://www.ncbi.nlm.nih.gov/pubmed/32732603
http://dx.doi.org/10.1097/MNM.0000000000001259

Ejemplares similares